Objectives-To assess the performance of first-trimester ultrasound (US) in identifying major fetal structural abnormalities in an unselected population.
S
creening for chromosomal abnormalities at 11 to 14 weeks' gestation by the combined test 1 has become a standard of antenatal care in many countries around the world. [2] [3] [4] At this stage, a detailed fetal anatomic evaluation can also be undertaken, with the aim of identifying fetuses with major structural anomalies early in pregnancy. 3, 5, 6 Counseling in patients with affected pregnancies can be done early, giving patients the necessary time to analyze their options of either terminating or continuing the pregnancy. [2] [3] [4] Using a basic fetal anatomy examination, Syngelaki et al 2 reported a 100% detection rate (DR) for acrania, alobar holoprosencephaly, exomphalos, gastroschisis, megacystis, and body stalk anomaly. They considered these defects as "always detectable" in the first trimester. The authors reported a 50% DR for major cardiac defects, congenital diaphragmatic hernia, and limb anomalies, and DR less than 10% for spina bifida and facial and kidney anomalies. 2 Rossi and Perfumo, 7 in a systematic review, found an overall DR of 51% for fetal structural defects at 11 to 14 weeks. Kenkhuis et al 8 found that, by using a standardized protocol in an unselected population, an ultrasound (US) at 12 to 13 weeks' gestation can detect 40% to 50% of all prenatally detectable fetal structural anomalies and 100% of those "expected to be detected" at this stage. A recent systematic review of first-trimester US screening in detecting fetal structural anomalies reported overall DRs of 32% to 60% in populations of varying risk and emphasized the importance of applying a standardized anatomic protocol in improving detection of all fetal anomalies. 5 The aims of this study were to use a standardized protocol for fetal structural assessment in the first trimester based on the protocol used for second-trimester anatomy assessment 9 and to evaluate the performance of such a protocol in the detection of major structural defects in an unselected population at 11 to 14 weeks' gestation.
Materials and Methods
We conducted a retrospective analysis of all pregnant patients who underwent US examination at 11 to 14 weeks in the Fetal Medicine Department of Filantropia Hospital, Bucharest, Romania, between October 2009 and December 2016.
Since October 2009, we have systematically used the Fetal Medicine Foundation (FMF) protocol (combined first-trimester screening) 1 to assess the risk for trisomy 21 and other aneuploidies at 11 to 14 weeks' gestation.
Maternal demographic data, medical histories, US findings, and biochemical results were recorded in the electronic database of the center. The aim of the examination was to establish the gestational age according to the crown-rump length (CRL) measurement, to measure the fetal heart rate and the nuchal translucency (NT) thickness, to diagnose multiple pregnancies and assess the chorionicity, and to detect major structural defects using a detailed fetal anatomy evaluation protocol. Assessment of the additional first-trimester US markers (nasal bone, tricuspid flow, and ductus venous flow) 1 was recommended if possible but was not considered mandatory.
All scans were performed by 1 of the 8 fetal medicine specialists who had obtained FMF Certificates of Competence in the 11-to 14-week scan. We used Voluson 730 Pro or Expert and E8 expert (GE Medical Systems, Zipf, Austria) US machines. In the majority of the cases, the examination was performed transabdominally, using 3-7.5-or 2-8-MHz curvilinear transducers. In selected cases (patients with a retroverted uterus, an increased maternal body mass index, or fibroids), we used the transvaginal approach (3-9-or 4-9-MHz transducers) or both routes to complete the examination. The mean time allocated for examination was 30 minutes. However, if the examination was not completed within the time frame, we completed the examination during the same visit after a short break. The lowest power output was used to reduce the fetal time exposure. Apart from the 2-dimensional (2D) US images, in some cases we also stored 2D cine loops, 3-dimensional (3D) volumes, or 3D rendering images for retrospective analysis.
First-Trimester Examination Protocol
We performed a systematic examination of the fetal anatomy in transverse parallel sections, longitudinal and coronal views, using the same principles of the secondtrimester US examination. 9 We always started with an overview of the fetus, examining the cranial and caudal poles at the time of CRL measurement and assessing the fetal position and orientation.
The fetal anatomy examination protocol aimed to demonstrate the transverse section of the head; midsagittal, transverse, and coronal sections of the face; parasagittal view of the thorax to demonstrate the diaphragm on both sides; transverse plane of the abdomen at the level of the stomach; umbilical cord insertion in the abdomen; transverse view of the bladder and paravesical view of the umbilical arteries using color Doppler; coronal view of the kidneys; and longitudinal view of the spine. We performed the examination of the limbs in longitudinal, coronal, and transverse sections to assess the 3 segments; the echogenicity of the bones; and the movements of the joints, the fingers, and toes. Examination of the heart was done in detail according to our protocol.
The fetal brain was examined in a transverse section at the level of the choroid plexus. We assessed the head shape, the falx cerebri, integrity of the calvaria, and the choroid plexus. Since 2012, we have used the midsagittal view to examine the posterior fossa and to measure the brain stem (BS) diameter and brain stem-to-occipital bone (BSOB) distance and to assess the BS-to-BSOB ratio. [10] [11] [12] [13] [14] [15] [16] The anatomy of the face was assessed in a midsagittal view, examining the profile, nasal bone, and integrity of the maxilla. We examined the orbits and anterior portion of the palate in transverse sections, and we assessed the retronasal triangle in a coronal view. 17 Early detection of cardiac structural abnormalities traditionally relies on the association with easy detectable markers such as increased NT, [18] [19] [20] tricuspid regurgitation, 21 and reversed ductus venous flow, 22 which were also assessed in our group.
In our study, the assessment of the fetal heart was performed systematically in the entire cohort using the same principles as for the second trimester. 23 A transabdominal scan was performed in all patients and a transvaginal scan in some of the patients to provide complementary information when the transabdominal approach was suboptimal or a cardiac abnormality was suspected. We assessed the fetal orientation and position, the abdominal situs, the 4-chamber view, and the outflow tracts with more emphasis on the color flow mapping. 24, 25 The examination consisted of performing a transverse sweep starting from the upper abdomen up to the level of the aortic arch, once in the B-mode and once with color Doppler, using a pulse repetition frequency of 4 to 5 kHz. In the 4-chamber view, we assessed the heart position, orientation, and size. We evaluated the size of the atria and ventricles, the crux, the offsetting of the atrioventricular valves, and the ventricular filling by color Doppler mapping. The origin of the aorta and pulmonary artery and the 3-vessel view were assessed in the B-mode and with color Doppler. We decreased the pulse repetition frequency to 1.3 kHz at the level of the aortic arch for the right subclavian artery examination.
Risk calculation for aneuploidies was performed at the same visit using a combination of data on maternal age, NT thickness, fetal heart rate, fetal nasal bone, tricuspid flow, ductus venous flow, free b-human chorionic gonadotropin level in maternal serum, and pregnancyassociated plasma protein A level in maternal serum. 1 The FMF algorithm, which takes into account a priori risk derived from the maternal age and maternal history and likelihood ratios derived from the individual values of the various US and serum markers, was used for risk calculation. 1, 3, 4 The risk for aneuploidies was considered high if an atrioventricular septal defect, 26 holoprosencephaly, 27 exomphalos, 27 megacystis, 27, 28 or a diaphragmatic hernia 29 was seen on the scan. The individual risk assessment results were discussed with the patients, usually right after the scan; the available options (US follow-up, diagnostic testing by chorionic villus sampling or amniocentesis, and, since 2015, the analysis of the cell-free DNA in the maternal blood) were presented. Patients were informed that a risk of 1 in 100 or more for any of the common trisomies was considered high, and diagnostic testing by an invasive procedure (chorionic villus sampling or amniocentesis) was offered in the high-risk cases. They were also informed of a small procedure-related risk of miscarriage.
30,31
Data Collection/Follow-up A follow-up examination was performed on all patients at 20 to 24 weeks, using the International Society of Ultrasound in Obstetrics & Gynecology protocols. 9 All data were stored in our local electronic database. We included in our analysis all cases of major structural anomalies diagnosed prenatally by US, postnatally by neonatal examination, or by postmortem examination. Structural defects associated with aneuploidies were also included in our study.
In cases of early termination or early spontaneous loss with informative US images but without postmortem examination, the US diagnosis was assumed to be correct. The structural anomalies suspected in the first trimester and confirmed in subsequent follow-up scans were counted as diagnosed in the first trimester.
We consider major structural anomalies those that are associated with short-or long-term severe morbidity or that are incompatible with life. 32, 33 An association of 2 or more major structural anomalies was considered a case of multiple structural defects.
We did not include in our anomaly count the cases of cystic hygroma, as we considered it as increased NT and not a structural defect per se. We excluded from our analysis the cases of borderline or moderate (<15 mm) ventriculomegaly and mild-to-moderate hydronephrosis (anteroposterior renal pelvis diameter of 6-15 mm). In our experience, hydronephrosis less than 15 mm has only minor consequences after birth in most cases. To our knowledge, the neurodevelopmental outcome in cases of isolated ventriculomegaly less than 15 mm is very similar to that in the general population. We also excluded uncomplicated pelvic kidney and uncomplicated single kidney from our analysis, as we consider those to be anatomic variants with no pathologic significance.
In cases with fetal structural anomalies, the patients were counseled regarding the prognosis and further management by a multidisciplinary team including a fetal medicine specialist, obstetrician, geneticist, pediatric surgeon, and neonatologist.
The postnatal outcome was obtained from the hospital neonatal database (87.5% of the patients) or directly from the patients. The neonate/fetus was considered normal if no anomaly was suspected or detected by the time of hospital discharge (at least 2 days after delivery).
This study did not require the approval of the Ethics Committee, as it represents a retrospective analysis of the routine prenatal examinations.
Results
Between October 2009 and December 2016, we examined 7480 unselected pregnant patients with 7576 fetuses. There were 96 cases of multiple pregnancy. The follow-up rate was 80.8% (the outcome was known for 6045 patients/6114 fetuses). The median maternal age was 29.62 (range, 16-45) years, and the median body mass index was 22.32 (range, 15-45) kg/m 2 . The median CRL was 65.45 (range, 45.1-84) mm. In 97% of the patients, the racial origin was white; conception was spontaneous in 95% of the patients. 34 Major chromosomal defects were diagnosed in 42 patients (0.69%). We diagnosed 41 cases of chromosomal abnormalities prenatally (37 patients in the first trimester and 4 patients in the second trimester), and 1 patient was diagnosed postnatally.
The prevalence of major structural defects in the study group was 1.89% (116 of 6114). There were 116 major structural anomalies. Of those, there were 5 fetuses with multiple structural defects and 111 fetuses with isolated major structural defects. Two cases of structural anomalies were diagnosed in twin pregnancies (in both cases, one fetus appeared normal and the other one was anomalous). The overall prenatal DR was 95.6%. The DR in the first trimester was 79% (92 of 116). Both cases of structural defects in multiple pregnancies were diagnosed in the first trimester. Nineteen cases (16.4%) of the structural anomalies were diagnosed in the second trimester. Five cases (4.3%) were diagnosed postnatally: 1 case of congenital lumbar hernia, 1 case of Goldenhar syndrome, 2 cases of congenital cardiac defects (1 case of aortic coarctation and 1 case of ventricular septal defect), and 1 case of oligodactyly (missing thumb). In 29.6% (27 of 92) of the cases diagnosed in the first trimester, there was an associated genetic condition.
The NT thickness was increased above the 95th percentile in 35% (41 of 116) of the fetuses with major structural defects. From this group, we detected 95% of the cases at 11 to 14 weeks. In the group with structural defects and normal NT, we diagnosed 70% of the cases in the first trimester. In the group of anomalies detected in the first trimester, a greater proportion (57%) was represented by patients with normal NT thickness.
The spectrum of fetal structural abnormalities encountered in our population is summarized in Table 1 .
Central Nervous System Abnormalities
We diagnosed all cases of acrania/anencephaly (10 of 10), all cases of alobar holoprosencephaly (7 of 7), and all cases of encephalocele (2 of 2) in the first trimester. Since 2012, when we started to evaluate the posterior fossa in the first trimester, we have diagnosed all of the cases of open spina bifida (OSB) by assessing the BS-to-BSOB ratio. However, the overall DR for OSB during the study period was 67% (2 of 3). We also suspected a Dandy-Walker malformation at 13 weeks' gestation (Figure 1 ), which was confirmed on a follow-up scan at 18 weeks' gestation. We diagnosed 1 of the 2 cases of sacral agenesis in the first trimester (Figure 2 ). There was 1 case of agenesis of the corpus callosum detected in the second trimester in our group.
Facial Defects
The overall first-trimester DR for facial abnormalities was 50%. We diagnosed 67% of the facial clefts (2 of 3; Figure 3 ). One case of isolated cleft palate was detected in the second trimester, and 1 case of Goldenhar syndrome was diagnosed postnatally.
Thoracic Anomalies
We diagnosed 67% (2 of 3) of the cases of isolated congenital diaphragmatic hernia. One of the patients presented at 12 weeks, with an isolated finding of an intrahepatic simple cyst (Figure 4) . At 19 weeks, a complete resolution of the cyst was noticed; however, the right hepatic lobe moved into the chest, and a right congenital diaphragmatic hernia was diagnosed. Therefore, we considered this case as an abnormality diagnosed in the first trimester, the cyst being an early manifestation of a right congenital diaphragmatic hernia. Cardiac Anomalies There were 35 major fetal structural cardiac defects within the group, representing a prevalence of 5.7 per 1000 births. We identified 26 cases in the first trimester, which represents a DR of 74.2%, while in the second trimester, we detected 7 additional cases (20%). The overall antenatal DR was 94.2%. There were 2 cases that were detected at birth-1 case of coarctation of the aorta and 1 symptomatic ventricular septal defect (VSD). The first trimester DR varied from 100% for a common arterial trunk (2 of 2), right atrial isomerism (1 of 1), an atrioventricular septal defect (4 of 4; Figure 5A ), and a double-outlet right ventricle (2 of 2) to 78% for a hypoplastic left heart/coarctation of the aorta (7 of 9; Figure 5B ), 75% for a right aortic arch (3 of 4; Figure 5C ), 62.5% for tetralogy of Fallot (5 of 8; Figure 5D ), and 25% for VSD (1 of 4). The only case of transposition of the great arteries was not detected in the first trimester. The DR in the first trimester excluding the VSDs was 81%. In cases of heart defects diagnosed in the first trimester, we did not have a postmortem examination for those that terminated before 14 weeks' gestation (69% [18 cases], of which only 5 cases were not associated with genetic problems). In 75% (6 cases) of the heart defects diagnosed in the first trimester and in which the pregnancy continued beyond 14 weeks, we had pathologic or clinical confirmation of the diagnosis.
Abdominal Wall Defects
All cases of exomphalos (6 of 6), gastroschisis (6 of 6), and body stalk anomalies (3 of 3) were detected during the first-trimester US scan. 
Urinary Anomalies
We achieved a first-trimester DR of 64% for major urinary abnormalities. All cases of persistent cloaca (1 of 1) and megacystis (6 of 6) were diagnosed in the first trimester. Bilateral renal agenesis (2 of 2), polycystic kidneys (1 of 1), and bilateral multicystic kidneys (1 of 1) were not detected at this stage of pregnancy.
Skeletal Anomalies
The overall DR of skeletal anomalies in the first trimester was 71%. We were able to diagnose all cases of aplasia-hypoplasia of the radius (3 of 3; Figure 6A ), 75% of the cases of digit defects (3 of 4; Figure 6B ), 67% of lethal skeletal dysplasias (2 of 3; Figure 6C ), and 50% of the transverse reductions of the limbs (1 of 2). One case of oligodactyly (missing thumb) was diagnosed postnatally.
Multiple Structural Malformations and Tumors
All cases of multiple structural malformations (5 of 5) and all cases of sacrococcygeal teratomas (2 of 2) were diagnosed at 11 to 14 weeks.
Discussion
To our knowledge, this work was the first study that evaluated the use of a first-trimester protocol for fetal structural examination, in a single center in Romania. Data on the performance of first-trimester US diagnosis of structural anomalies are important for both clinical practice and public health decision making. The prevalence of major structural defects in our study was 1.89% (116 of 6114), comparable to the rates reported by other studies in unselected low-risk populations. [35] [36] [37] [38] The prevalence of structural defects in multiple pregnancies was 2.1%-lower than than in the general literature 39 ; this finding has to be interpreted in the context Vayna et al-11 to 14 Weeks' Scan of small numbers. The DR in the first trimester was 79% (92 of 116). In 29.6% (27 of 92) of our cases, there was an associated genetic condition. We decided not to exclude the cases of aneuploidy, as in some of these cases the structural defect was an important factor in establishing the genetic diagnosis in the first trimester. The NT thickness was increased above the 95th percentile in 35% (41 of 116) of the cases with major structural defects. From this group, we detected 95% of the cases at 11 to 14 weeks. In the group with structural defects and normal NT, we diagnosed 70% of the cases in the first trimester. However, in the group of anomalies detected in the first trimester, a greater proportion was represented by the cases with normal NT thickness (57%).
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We diagnosed all cases of acrania, alobar holoprosencephaly, exomphalos, gastroschisis, megacystis, and body stalk anomalies. These anomalies, according to Syngelaki et al, 2 fall in the group of structural defects that should always be detected in the first trimester. There were 38 cases of such anomalies, representing 42% of the total structural defects we diagnosed in the first trimester. The rest of 54 structural defects (58%) diagnosed at 11 to 14 weeks fall into the category of anomalies that are potentially detectable in the first trimester either by assessing an indirect sign (eg, posterior fossa in OSB) or by a comprehensive examination of the target organ.
The highest DRs were achieved for abdominal wall defects (100%), central nervous system anomalies (88%), cardiac defects (74%), and skeletal anomalies (71%). Abdominal wall defects are generally easily detectable in the first trimester, and their classification was recently clarified by Panaitescu et al. 40 We achieved a higher DR for central nervous system malformations in comparison to other reports 2, [35] [36] [37] 41 due to the systematic evaluation of the posterior brain. To increase the DR of OSB in the first trimester, new intracranial markers have been described. [10] [11] [12] [13] [14] [15] [16] The fourth ventricle diameter (intracranial translucency) measured in the midsagittal view of the fetal head is reduced or obliterated in fetuses with OSB. A BS diameter above the 95th percentile, an increased BS-to-BSOB ratio above the 95th percentile, and a reduced cisterna magna width below the 5th percentile represent some other changes of the posterior fossa in fetuses with OSB at 11 to 14 weeks. Combining all these parameters, OSB can be effectively diagnosed at 11 to 14 weeks when the examination is performed by experienced operators. 42 The use of the BS-to-BSOB ratio has been extended beyond detection of OSB. Although the data are limited, it has been suggested that the ratio below the fifth percentile is seen in fetuses with Dandy-Walker complex. 15 We diagnosed 2 cases of OSB and 1 case of Dandy-Walker malformation. This assessment did not increase the time of examination, as it was performed in the same midsagittal view used for the measurement of NT thickness.
The DR of the cardiac defects in the first trimester, excluding VSDs, was 81%. Eleven of the 26 fetuses with major cardiac abnormalities detected in the first trimester had an increased NT; therefore, we conclude that systematic evaluation of the fetal heart substantially increases early detection of cardiac abnormalities. We also noted that this approach did not increase the time of scanning appreciably, since the angle of incidence and magnification are similar to the ones used for tricuspid flow assessment.
Of the 35 fetuses with cardiac abnormalities, there were 13 fetuses with chromosomal abnormalities or genetic syndromes. Twelve of the 13 belonged to the group that were detected in the first trimester.
Skeletal dysplasias are, by definition, growth disturbances of bones. Our experience is that lethal skeletal dysplasias can be diagnosed or suspected at 11 to 14 weeks' gestation. The DR of limb reduction defects could be improved by a stricter adherence to the protocol.
The urorenal malformations are interesting in the way that they can be clearly divided into 2 subgroups: a subgroup of malformations that are always detectable in the first trimester (such as megacystis) and a subgroup of malformations that we would rather expect to detect in the second trimester (such as hydronephrosis).
2 Bilateral renal agenesis is the one example of a lethal malformation that theoretically could be diagnosed in the first trimester, but it is actually discovered in the second trimester in almost all instances.
In the present context of cell-free DNA screening for aneuploidies, 43 the role of the first-trimester scan has been questioned by some, 44 whereas others emphasize the major role of first-trimester US in the prenatal assessment. 45, 46 The advantage of early diagnosis of structural defects that are either lethal or associated with severe disabilities is that the parents are offered the option of early and safer termination of pregnancy. Moreover, in cases with correctable anomalies, prenatal and postnatal follow-up can be organized by a multidisciplinary team. In patients who undergo invasive testing, a more detailed genetic analysis can be performed in the presence of a structural anomaly, using methods such as microarray analysis or next-generation tests. 47 The disadvantage of early diagnosis is that the counseling is sometimes difficult, and the parents may choose to have a termination before a complete diagnosis and meaningful discussion on prognosis are possible. Our results show that by applying a systematic detailed US protocol, many structural abnormalities are easily detected during the first trimester, as previously demonstrated by other authors. 36 However, we achieved a higher DR of structural abnormalities at this stage of pregnancy because of the highly qualified personnel and the equipment that provided us high-resolution images. These facts may represent one of the weaknesses of our study.
One of the main weaknesses of our study was that confirmation of the US diagnosis either by a postnatal diagnosis, postmortem examination, or second-trimester US was not always possible because of early pregnancy termination. This limitation was due to inherent difficulty of making a specific diagnosis based on a pathologic examination of the first-trimester products of conception, which is especially difficult in cases of cardiac and intracranial defects. Overall, we had a pathologic or clinical confirmation in 78% of all cases of structural defects diagnosed prenatally. Nevertheless, in most cases, a rational course of management can be developed based on the diagnosis of a fetal anomaly in the first trimester. We think that the advantages of firsttrimester diagnosis clearly outweigh its drawbacks, and in the instances with negative results, the parents can be reassured with a high level of confidence.
